Nautilus Biotechnology, Inc.
NAUT
$0.08
Change (1 day)
$3.46
Year High
$2.19
Year Low
Categories
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Earnings for Nautilus Biotechnology, Inc. (NAUT)
Earnings in 2023 (TTM): $-63,675,000
According to Nautilus Biotechnology, Inc.'s latest financial reports the company's current earnings (TTM) are $-63,675,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Nautilus Biotechnology, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-63,675,000 | $-63,675,000 |
| 2022 | $-57,924,000 | $-63,740,000 |
| 2021 | $-50,315,000 | $-50,315,000 |
| 2020 | $-15,619,000 | $-15,619,000 |
| 2019 | $-9,618 | $-9,618 |
| 2018 | $626.6 M | $626.6 M |